05-05-2024, 08:57 PM
Whzs Govt sets wheat purchase target at 6.95 million tonnes
KARACHI:Young all-rounder Shadab Khan once again showed why he is one of the country鈥檚 most sought-after young talent as he followed up his four-wicket haul with a superb century to help Pakistan A score 512 and claim a 166-run lead against Zimbabwe A on day three of their four-day unofficial Test at the Queens Sports Club in Bulawayo, Zimbabwe yesterday.Pakistan A resumed their adidas campus 80s first innings on 284-5 and added 228 runs with Shadab scoring 132 off 161 balls, hitting 19 fours and samba adidas og two big sixes while Saud Shakeel scored 97 runs to build a 130-run seventh wicket stand with Shadab.Unofficial Test: Zain half-century takes Pakistan A to 284-5Other than Shakeel and adidas samba bianche Shadab, Zain Abbas (78), Saifullah Bangash (42), Sohaib Maqsood (41), Jaahid Ali (31), Muhammad Asghar (31) and Umar Amin (30) were also among the runs. For Zimbabwe, Brian Vitori took three wickets while Carl Mumba and John Nyumbu took two apiece.At the end of the day鈥檚 play, Zimbabwe were struggling at 53-2 as Mir Hamza and Ghula IPSOGENhas announced tha dunk low mujer t it has signed an agreement with DNAVision, a provider of pharmacogenomic services in Europe. With this agreement, IPSOGEN gains the capability to offer its portfolio of breast cancer profiling tests to institutions and patients in a CLIA/ISO17025 certified environment.鈥淭his agreement with DNAVision, a recognized provider of high quality pharmacogenomic tests enables IPSOGEN to la air jordan unch a new generation of IVD profiling diagnostic products addressing unmet needs in guiding breast cancer therapies鈥?said Vincent Fert, president and CEO of IPSOGEN.鈥淒NAVision microarray testing facilities have the most advanced quality standards in Europe. nike dunks low IPSOGEN can now offer its microarray profiling services at the level of quality of quantitative PCR, the industry gold standard. This agreement definitely positions IPSOGEN as a technology leader in diagnostic gene profiling鈥?added Jean-Marc Le Doussal, IPSOGEN Director of Breast Cancer Program.鈥淲e are delighted to combine our qual
KARACHI:Young all-rounder Shadab Khan once again showed why he is one of the country鈥檚 most sought-after young talent as he followed up his four-wicket haul with a superb century to help Pakistan A score 512 and claim a 166-run lead against Zimbabwe A on day three of their four-day unofficial Test at the Queens Sports Club in Bulawayo, Zimbabwe yesterday.Pakistan A resumed their adidas campus 80s first innings on 284-5 and added 228 runs with Shadab scoring 132 off 161 balls, hitting 19 fours and samba adidas og two big sixes while Saud Shakeel scored 97 runs to build a 130-run seventh wicket stand with Shadab.Unofficial Test: Zain half-century takes Pakistan A to 284-5Other than Shakeel and adidas samba bianche Shadab, Zain Abbas (78), Saifullah Bangash (42), Sohaib Maqsood (41), Jaahid Ali (31), Muhammad Asghar (31) and Umar Amin (30) were also among the runs. For Zimbabwe, Brian Vitori took three wickets while Carl Mumba and John Nyumbu took two apiece.At the end of the day鈥檚 play, Zimbabwe were struggling at 53-2 as Mir Hamza and Ghula IPSOGENhas announced tha dunk low mujer t it has signed an agreement with DNAVision, a provider of pharmacogenomic services in Europe. With this agreement, IPSOGEN gains the capability to offer its portfolio of breast cancer profiling tests to institutions and patients in a CLIA/ISO17025 certified environment.鈥淭his agreement with DNAVision, a recognized provider of high quality pharmacogenomic tests enables IPSOGEN to la air jordan unch a new generation of IVD profiling diagnostic products addressing unmet needs in guiding breast cancer therapies鈥?said Vincent Fert, president and CEO of IPSOGEN.鈥淒NAVision microarray testing facilities have the most advanced quality standards in Europe. nike dunks low IPSOGEN can now offer its microarray profiling services at the level of quality of quantitative PCR, the industry gold standard. This agreement definitely positions IPSOGEN as a technology leader in diagnostic gene profiling鈥?added Jean-Marc Le Doussal, IPSOGEN Director of Breast Cancer Program.鈥淲e are delighted to combine our qual
